Abstract
Coronavirus disease 2019 (COVID-19) is highly infectious and seriously harmful to human health. According to the clinical characteristics of COVID-19, it can be classified into mild, moderate, severe and critical ones. The treatment for critical cases is an important factor of reducing the mortality rate of the disease and is always dependent on the intensive care unit (ICU). The ICU therapy strategies involve not only curing the critical cases, but also avoiding cross infection in the same ward. Therefore, we have formulated detailed response management strategies, including the establishment of core groups, standardization of diagnosis and treatment process, strengthening personnel management, multimodal training assessment, and overall allocation of protection materials. We hope the strategies can provide reference for relevant ICUs.
| Translated title of the contribution | Management of novel coronavirus infection in ICU |
|---|---|
| Original language | Chinese (Traditional) |
| Pages (from-to) | 488-491 |
| Number of pages | 4 |
| Journal | Journal of Xi'an Jiaotong University (Medical Sciences) |
| Volume | 41 |
| Issue number | 4 |
| DOIs | |
| State | Published - 5 Jul 2020 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Management of novel coronavirus infection in ICU'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver